2018
DOI: 10.1038/s41467-018-07490-6
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems

Abstract: Adverse drug reactions (ADRs) restrict the maximum doses applicable in chemotherapy, which leads to failure in cancer treatment. Various approaches, including nano-drug and prodrug strategies aimed at reducing ADRs, have been developed, but these strategies have their own pitfalls. A renovated strategy for ADR reduction is urgently needed. Here, we employ an enzymatic supramolecular self-assembly process to accumulate a bioorthogonal decaging reaction trigger inside targeted cancer cells, enabling spatiotempor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
110
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 177 publications
(110 citation statements)
references
References 35 publications
0
110
0
Order By: Relevance
“…Our current study provides a thorough understanding of the catalytic mechanism of thermolysin, in particular, a new methodology for bottom-up nanofabrication of future soft-gel materials, and has instructive significance on the regulation of peptide sequences, secondary structure, morphology, and mechanical property of self-assembled hydrogels with precise design and control in molecular level by thermolysin and functional applications of peptide materials. [49][50][51][52][53][54]…”
Section: Resultsmentioning
confidence: 99%
“…Our current study provides a thorough understanding of the catalytic mechanism of thermolysin, in particular, a new methodology for bottom-up nanofabrication of future soft-gel materials, and has instructive significance on the regulation of peptide sequences, secondary structure, morphology, and mechanical property of self-assembled hydrogels with precise design and control in molecular level by thermolysin and functional applications of peptide materials. [49][50][51][52][53][54]…”
Section: Resultsmentioning
confidence: 99%
“…It is also worth noting that some very interesting work in developing new bioorthogonal reactions has been reported. [147][148][149][150] Though these new reactions may not have been used in targeted drug delivery, they offer additional opportunities in this area of research. We hope that the publication of this review will provide researchers a good reference for choosing a suitable chemical linker and chemical strategies for their prodrug design, and more importantly will stimulate more research into overcoming obstacles that this field still faces in developing smart drugs for clinical applications.…”
Section: Discussionmentioning
confidence: 99%
“…[20][21][22] These reversible, controllable, and dynamic noncovalent interactions allow these self-assembled systems of biomolecules to adapt well to the physiological environment to fully optimize their biological functions. [23][24][25][26] For example, the specic interaction among macromolecules causes a conformational change in the partner macromolecule to activate one of the binding partners to trigger a biological cascade. 27 In particular, low molecular weight peptides exhibit outstanding advantages (such as inherent biocompatibility, potential biodegradability, structural programmability, and easy preparation) compared to other existing self-assembly motifs.…”
Section: Introductionmentioning
confidence: 99%